DNA X investor reports 6.8% ownership stake
DNA X, Inc. reports that investor Laurence W. Lytton beneficially owns 100,521 shares of its common stock, representing 6.8% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
DNA X, Inc. reports that investor Laurence W. Lytton beneficially owns 100,521 shares of its common stock, representing 6.8% of the class. This ownership consists of 61,633 shares with sole voting and dispositive power and 38,888 shares with shared voting and dispositive power.
The ownership percentage is based on 1,488,268 shares of common stock outstanding as of May 14, 2026. Lytton also holds warrants to purchase 22,222 additional shares that are excluded from the reported beneficial ownership due to a 4.99% beneficial ownership limitation on those warrants.
Key Figures
Key Terms
beneficially owned financial
sole voting power financial
beneficial ownership limitation regulatory
dispositive power financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much of DNA X, Inc. does investor Laurence W. Lytton own according to the SONM Schedule 13G/A?
How was Laurence W. Lytton’s 6.8% ownership in DNA X, Inc. calculated in the SONM Schedule 13G/A?
What class of securities in DNA X, Inc. does the SONM Schedule 13G/A cover for Laurence W. Lytton?
AI-generated analysis. How Rhea-AI works. Not financial advice.